Neuroinflammation

Cells and Tissue Interfaces#

Microglia#

Microglia are the CNS-resident immune cells that survey their local environment, remove debris, remodel synapses, and respond to infection or injury. Single-cell studies show that reactive microglia occupy diverse, time- and region-dependent states.

The familiar “M1” and “M2” labels can be useful experimental shorthand for selected pro-inflammatory and repair-associated markers, but they do not describe two fixed cell types or the full range of human microglial biology.^{[1]Microglia in neurodegenerative diseases: mechanism and potential therapeutic targetsGao C, Jiang J, Tan Y et al. · 2023Open reference 1 ↓}

Microglial effects are context-dependent. Around protein aggregates, some states support clearance, whereas others release inflammatory mediators, activate the NLRP3 Inflammasome, or promote pathological protein spread. The direction can change with disease stage, anatomical region, genetics, and signals from infiltrating immune cells.^{[1]Microglia in neurodegenerative diseases: mechanism and potential therapeutic targetsGao C, Jiang J, Tan Y et al. · 2023Open reference 1 ↓}

Astrocytes and the Neurovascular Unit#

Astrocytes regulate neurotransmitter handling, metabolic support, and the environment surrounding neurons and blood vessels. In multiple-sclerosis tissue and experimental models, astrocyte and microglial states respond to bile-acid receptor signaling, illustrating that glial inflammation is shaped by metabolic as well as immune inputs.^{[4]Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammationPavan Bhargava, Matthew D. Smith, Leah Mische et al. · 2020Open reference 4 ↓}

The Blood-Brain Barrier is a multicellular interface formed by vascular endothelial cells, supporting cells, basement membranes, and glial end-feet. Loss of endothelial tight junction integrity can allow more circulating mediators and immune cells to influence CNS tissue.

In multiple sclerosis, barrier disruption can appear early, although whether it initiates lesions or partly reflects ongoing inflammation remains unsettled.^{[2]Vascular Pathology in Multiple Sclerosis: Reframing Pathogenesis Around the Blood-Brain BarrierJonathan I. Spencer, Jack S. Bell, Gabriele C. DeLuca · 2018Open reference 2 ↓}

How Peripheral and Gut Signals Reach the CNS#

The Gut-Brain Axis offers several routes by which intestinal events may alter CNS immune activity. These routes should be separated rather than compressed into a single “leaky gut causes brain inflammation” claim.

1. Barrier and vascular signaling: microbial products and circulating cytokines can activate vascular or immune signaling at CNS interfaces; altered barrier integrity may increase their influence.^{[2]Vascular Pathology in Multiple Sclerosis: Reframing Pathogenesis Around the Blood-Brain BarrierJonathan I. Spencer, Jack S. Bell, Gabriele C. DeLuca · 2018Open reference 2 ↓[3]The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled NeuroinflammationComer AL, Carrier M, Tremblay ME et al. · 2020Open reference 3 ↓}
2. Immune-cell trafficking: intestinal immune programs can affect circulating T-cell populations. A review of multiple-sclerosis evidence describes intestine-associated Th17 responses as one route into CNS autoimmunity, while emphasizing that human intervention evidence remains limited.^{[5]Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?V. Martinelli, M. Albanese, M. Altieri et al. · 2022Open reference 5 ↓}
3. Microbial metabolites: Short-Chain Fatty Acids (SCFAs), bile acids, and tryptophan-derived molecules can modify barrier, immune, and glial signaling. Their effects depend on molecule, concentration, receptor, and disease model; they are not uniformly anti-inflammatory.^{[4]Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammationPavan Bhargava, Matthew D. Smith, Leah Mische et al. · 2020Open reference 4 ↓[6]Sodium Butyrate Attenuates Microglia-Mediated Neuroinflammation by Modulating the TLR4/MyD88/NF-kB Pathway and Microbiome-Gut-Brain Axis in Cardiac Arrest MiceJianfei Sun, Liping Lu, Yingtao Lian et al. · 2025Open reference 6 ↓}
4. Neural signaling: vagal and enteric pathways can transmit physiological information without requiring a bacterium or metabolite to enter brain tissue. Reviews of autism and Parkinson’s-related models treat this as one route among several, not proof that a gut change caused a CNS lesion.^{[7]Zhou 2025 -- Intervention and Research Progress of Gut Microbiota-Immune-Nervous System in Autism Spectrum Disorders Among StudentsMin Zhou, Baoming Niu, Jiarui Ma et al. · 2025Open reference 7 ↓[8]Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein PathologyKaren Pendergrass · 2025Open reference 8 ↓}

Gut Dysbiosis is therefore a possible upstream contributor, not a synonym for neuroinflammation. A microbiome association becomes a mechanistic claim only when the intervening barrier, immune, metabolic, or neural steps are supported.^{[5]Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?V. Martinelli, M. Albanese, M. Altieri et al. · 2022Open reference 5 ↓[7]Zhou 2025 -- Intervention and Research Progress of Gut Microbiota-Immune-Nervous System in Autism Spectrum Disorders Among StudentsMin Zhou, Baoming Niu, Jiarui Ma et al. · 2025Open reference 7 ↓}

What Intervention Studies Establish#

Preclinical intervention results can test mechanisms without establishing clinical treatment. In a mouse cardiac-arrest model, sodium Butyrate altered gut measures, TLR4/MyD88/NF-kB signaling, microglial marker patterns, and neurological outcomes.

That experiment supports pathway plausibility in that model; it does not establish butyrate as a general treatment for neuroinflammatory disease.^{[6]Sodium Butyrate Attenuates Microglia-Mediated Neuroinflammation by Modulating the TLR4/MyD88/NF-kB Pathway and Microbiome-Gut-Brain Axis in Cardiac Arrest MiceJianfei Sun, Liping Lu, Yingtao Lian et al. · 2025Open reference 6 ↓}

In multiple sclerosis research, human metabolomics identified altered bile-acid profiles, while cell and EAE experiments found that TUDCA affected astrocyte and microglial states through GPBAR1.

The study links a human association to experimental mechanism, but the disease-modifying effect was demonstrated in a model rather than a therapeutic trial in people with MS.^{[4]Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammationPavan Bhargava, Matthew D. Smith, Leah Mische et al. · 2020Open reference 4 ↓}

A review of small randomized trials of immunoregulatory or anti-inflammatory agents in autism reported some symptom signals and mixed findings, with short follow-up and small samples limiting inference.

Those trials do not make neuroinflammation a diagnostic test for autism or show that one inflammatory mechanism explains all participants.^{[12]Arteaga-Henriquez 2023 -- Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with ASDGara Arteaga-Henriquez, Laura Gisbert, Josep Antoni Ramos-Quiroga · 2023Open reference 12 ↓}